Literature DB >> 7762663

Interaction of endogenous nitric oxide and CGRP in sensory neuron-induced gastric vasodilation.

R Y Chen1, P H Guth.   

Abstract

Stimulation of capsaicin-sensitive sensory nerves induces gastric mucosal hyperemia, which is mediated in part by both calcitonin gene-related peptide (CGRP) and nitric oxide (NO). In the present study, we used in vivo microscopy in anesthetized rats to determine 1) whether these agents were released locally at the submucosal level and, if so, 2) whether CGRP dilates arterioles via release of endothelium-derived NO. Intragastric capsaicin (160 microM) dilated submucosal arterioles from 25 +/- 3 to 67 +/- 8 microns. The intragastric capsaicin-induced vasodilation was markedly reversed not only by intravenous administration of the NO synthesis inhibitor NG-nitro-L-arginine methyl ester (L-NAME) but also by submucosal suffusion of either L-NAME or the CGRP receptor antagonist human CGRP-(8-37). The latter findings indicate that both NO and CGRP are released locally at the submucosal level. Submucosal application of CGRP induced dose-dependent dilation of gastric submucosal arterioles, which was significantly attenuated by L-NAME. However, at the same degree of vasodilation (42 microns), the dilation induced with submucosal CGRP was much less attenuated by NO synthesis inhibition (-28%) compared with that induced with intragastric capsaicin (-79%). This indicates that endothelium-derived NO released by CGRP was not the only source of submucosal NO in the latter response. There must be another as yet undetermined source of submucosal NO, e.g., possibly nitroxidergic nerves.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7762663     DOI: 10.1152/ajpgi.1995.268.5.G791

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach.

Authors:  Katsushi Nishihara; Yoshihisa Nozawa; Motoko Nakano; Hirofusa Ajioka; Naosuke Matsuura
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

2.  An open-label, randomized, cross-over bioequivalence study of lafutidine 10 mg under fasting condition.

Authors:  Bhupesh Dewan; Raghuram Chimata
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

3.  Peripheral corticotropin-releasing factor receptor type 2 activation increases colonic blood flow through nitric oxide pathway in rats.

Authors:  Yasutada Akiba; Jonathan D Kaunitz; Mulugeta Million
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

4.  Gastroprotection induced by capsaicin in healthy human subjects.

Authors:  Gyula Mózsik; János Szolcsányi; István Rácz
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

5.  Effects of okadaic acid on rat colon.

Authors:  M Hosokawa; H Tsukada; T Saitou; M Kodama; M Onomura; H Nakamura; K Fukuda; Y Seino
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

6.  Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial.

Authors:  Bhupesh Dewan; Nisha Philipose
Journal:  Gastroenterol Res Pract       Date:  2011-05-05       Impact factor: 2.260

Review 7.  The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension.

Authors:  Charmaine C W Lo; Seyed M Moosavi; Kristen J Bubb
Journal:  Front Physiol       Date:  2018-08-23       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.